Get the Stockscreener App
8.94
0.00%
0.00
After Hours:
8.94
Anika Therapeutics Inc stock is traded at $8.94, with a volume of 72,979.
It is up +0.00% in the last 24 hours and up +10.23% over the past month.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.
See More
Previous Close:
$8.94
Open:
$8.92
24h Volume:
72,979
Relative Volume:
0.63
Market Cap:
$128.90M
Revenue:
$166.88M
Net Income/Loss:
$-74.18M
P/E Ratio:
-1.7633
EPS:
-5.07
Net Cash Flow:
$1.14M
1W Performance:
-4.69%
1M Performance:
+10.23%
6M Performance:
-46.21%
1Y Performance:
-63.60%
1-Day Range:
$8.81
$9.0413
1-Week Range:
$8.81
$9.50
52-Week Range:
$7.8701
$26.00
Anika Therapeutics Inc Stock (ANIK) Company Profile
Name
Anika Therapeutics Inc
Sector
Phone
(781) 457-9000
Address
32 WIGGINS AVENUE, BEDFORD, MA
Compare ANIK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ANIK
Anika Therapeutics Inc
|
8.94 | 128.90M | 166.88M | -74.18M | 1.14M | -5.07 |
|
ZTS
Zoetis Inc
|
151.75 | 67.95B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.27 | 48.64B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.74 | 43.86B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.30 | 21.74B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
394.62 | 18.11B | 2.99B | 1.21B | 1.13B | 25.06 |
Anika Therapeutics Inc Stock (ANIK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-17-25 | Initiated | B. Riley Securities | Buy |
| Nov-01-24 | Reiterated | Barrington Research | Outperform |
| Aug-14-23 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Mar-07-23 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Nov-09-22 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Oct-14-22 | Resumed | Stephens | Equal-Weight |
| Mar-09-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Mar-09-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| Nov-16-21 | Initiated | Stephens | Overweight |
| Jul-16-21 | Initiated | UBS | Neutral |
| Dec-16-20 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| May-08-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Jan-21-20 | Upgrade | Sidoti | Neutral → Buy |
| Jan-10-20 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
| Nov-05-19 | Initiated | BWS Financial | Sell |
| Sep-24-19 | Reiterated | Barrington Research | Outperform |
| Sep-23-19 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
| Jul-25-19 | Upgrade | First Analysis Sec | Neutral → Strong Buy |
| Feb-22-19 | Downgrade | First Analysis Sec | Outperform → Neutral |
| Feb-22-19 | Downgrade | Sidoti | Buy → Neutral |
| Jul-27-18 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Jun-20-18 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Jun-20-18 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| May-04-18 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Feb-23-18 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Jan-24-18 | Upgrade | First Analysis Sec | Equal-Weight → Overweight |
| Oct-27-17 | Reiterated | Barrington Research | Outperform |
| May-09-16 | Upgrade | Singular Research | BUY - Long-Term → Buy |
| Apr-27-16 | Downgrade | Northland Capital | Outperform → Market Perform |
| Feb-26-16 | Reiterated | Barrington Research | Outperform |
View All
Anika Therapeutics Inc Stock (ANIK) Latest News
Published on: 2025-09-08 20:31:28 - beatles.ru
Trendline Breach Raises Concern for Anika Therapeutics Inc. Investors2025 Market Overview & Entry Point Confirmation Signals - beatles.ru
What is the target price for Anika Therapeutics Inc. stock2025 Price Targets & Consistent Profit Alerts - beatles.ru
Should you buy the dip on Anika Therapeutics Inc.July 2025 Catalysts & Safe Entry Trade Reports - beatles.ru
Will Anika Therapeutics Inc. rebound enough to break even2025 Bull vs Bear & Smart Money Movement Alerts - Newser
Statistical indicators supporting Anika Therapeutics Inc.’s strengthInsider Buying & Expert-Curated Trade Recommendations - Newser
What data driven models say about Anika Therapeutics Inc.’s futureQuarterly Profit Summary & Long Hold Capital Preservation Tips - Newser
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc.ANIK - FinancialContent
How cyclical is Anika Therapeutics Inc.’s revenue stream2025 Technical Overview & Consistent Profit Alerts - خودرو بانک
Does Anika Therapeutics Inc. have declining or rising EPSStop Loss & Weekly High Conviction Trade Ideas - خودرو بانک
Risk adjusted return profile for Anika Therapeutics Inc. analyzedJuly 2025 Update & Free Real-Time Market Sentiment Alerts - Newser
Can Anika Therapeutics Inc. expand into new marketsPortfolio Performance Report & Fast Gain Stock Trading Tips - خودرو بانک
Visual analytics tools that track Anika Therapeutics Inc. performanceJobs Report & Smart Swing Trading Alerts - Newser
Real time breakdown of Anika Therapeutics Inc. stock performanceMarket Performance Recap & Reliable Price Breakout Alerts - Newser
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Anika Therapeutics Announces Inducement Grants for New Hire Under Nasdaq Listing Rule 5635(c)(4) - AInvest
2,500 Shares at $9.15: Anika Therapeutics Awards Inducement Stock Options to New Non-Executive Hire - Stock Titan
Understanding Anika Therapeutics Inc.’s price movementJuly 2025 Highlights & Entry Point Confirmation Signals - Newser
Regression analysis insights on Anika Therapeutics Inc. performanceMarket Performance Report & Daily Entry Point Alerts - Newser
Price momentum metrics for Anika Therapeutics Inc. explainedPortfolio Gains Summary & Advanced Technical Analysis Signals - Newser
Does Anika Therapeutics Inc. fit your quant trading modelJuly 2025 Intraday Action & Community Consensus Stock Picks - Newser
Pomerantz LLP Investigates Potential Claims Involving Anika Therapeutics Investors - geneonline.com
Published on: 2025-09-04 09:02:32 - Newser
Will Anika Therapeutics Inc. stock recover after recent dropMarket Rally & Free Risk Controlled Daily Trade Plans - Newser
Is Anika Therapeutics Inc. stock bottoming outJuly 2025 Market Mood & Advanced Technical Analysis Signals - Newser
How hedge fund analytics apply to Anika Therapeutics Inc. stockFed Meeting & Risk Managed Investment Strategies - Newser
What to expect from Anika Therapeutics Inc. in the next 30 daysWeekly Profit Report & Verified Swing Trading Watchlist - Newser
Sentiment analysis tools applied to Anika Therapeutics Inc.Weekly Trade Review & Daily Chart Pattern Signal Reports - Newser
Live market analysis of Anika Therapeutics Inc.Market Performance Recap & Verified Technical Trade Signals - Newser
Is Anika Therapeutics Inc. gaining market shareBreakout Watch & Fast Entry and Exit Trade Plans - خودرو بانک
How institutional ownership impacts Anika Therapeutics Inc. stock2025 Stock Rankings & Community Trade Idea Sharing Platform - Newser
Will Anika Therapeutics Inc. price bounce be sustainableWeekly Trade Report & Free Safe Capital Growth Stock Tips - Newser
Is Anika Therapeutics Inc. stock entering bullish territoryMarket Movers & Advanced Swing Trade Entry Plans - Newser
Will Anika Therapeutics Inc. benefit from geopolitical trendsInsider Selling & Daily Profit Focused Screening - خودرو بانک
Real time scanner hits for Anika Therapeutics Inc. explainedQuarterly Market Review & Smart Allocation Stock Tips - Newser
Tools to monitor Anika Therapeutics Inc. recovery probabilityJuly 2025 Recap & Expert Curated Trade Ideas - Newser
Is Anika Therapeutics Inc. forming a bottoming base2025 Winners & Losers & Long-Term Growth Plans - Newser
What are Anika Therapeutics Inc.’s recent SEC filings showingRate Cut & Entry and Exit Point Strategies - خودرو بانک
Tick level data insight on Anika Therapeutics Inc. volatility2025 Stock Rankings & Real-Time Volume Triggers - Newser
Using fundamentals and technicals on Anika Therapeutics Inc.2025 Historical Comparison & Free Expert Approved Momentum Trade Ideas - Newser
Can a trend reversal in Anika Therapeutics Inc. lead to recoveryWeekly Risk Report & Trade Opportunity Analysis Reports - Newser
Applying Wyckoff theory to Anika Therapeutics Inc. stockPortfolio Profit Report & Free Community Consensus Stock Picks - Newser
Aug Ideas: What are Anika Therapeutics Inc.’s technical support levels - خودرو بانک
Anika Therapeutics Inc Stock (ANIK) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.98%
3.36%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):